Skip to content

To assess whether providing Kenya?s first line anti-malarial treatment in shops at a subsidised price can increase the share of young children who receive appropriate treatment for malaria

The impact of retail sector delivery of artemether-lumefantrine on effective malaria treatment of children under five in Kenya

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN59275137
Enrollment
1161
Registered
2008-04-25
Start date
2008-05-07
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malaria Infections and Infestations Unspecified malaria

Interventions

This is a pre-post randomised cluster controlled design, with clusters (sub-locations) randomly allocated to 9 intervention and 9 control groups. We will need to collect data on 1,161 homesteads in th

Sponsors

Kenya Medical Research Institute (KEMRI) Wellcome Trust Research Programme (Kenya)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Added as of 27/01/2009: Please note that the specified minimum amount of time for which the selected retail outlets should have been functioning has been identified as a minimum period of six months prior to the baseline survey. Initial information at time of registration: 1. All children under five years of age (either sex) from whom care is sought for fever from participating retail shops serving the population in the intervention sub-locations 2. Selected retail outlets either within or serving the intervention sub-locations which are perceived to be well established, respected businesses by the local community, who stock anti-malarials or anti-pyretics and have been functioning for a specified minimum amount of time (time of functioning to be determined following baseline retail census)

Exclusion criteria

Exclusion criteria: Added as of 27/01/2009: Please note that the specified minimum amount of time for which the selected retail outlets should have been functioning has been identified as a minimum period of six months prior to the baseline survey. Current information as of 16/04/2010: 1. Children less than 3 months. These children will be referred directly to a health facility. 2. Children 3 - 59 months, suffering from Integrated Management of Childhood Illness (IMCI) danger signs. These children will be referred directly to a health facility. 3. Retail shops serving the intervention sub-locations that do not sell anti-pyretics or anti-malarials, have been functioning for less than the specified amount of time defined from the baseline retail census, and are not perceived to be well established, respected businesses by the local community Initial information at time of registration: 1. Children under 5 kg suffering from Integrated Management of Childhood Illness (IMCI) danger signs. These children will be referred directly to a health facility. 2. Retail shops serving the intervention sub-locations that do not sell anti-pyretics or anti-malarials, have been functioning for less than the specified amount of time defined from the baseline retail census, and are not perceived to be well established, respected businesses by the local community

Design outcomes

Primary

MeasureTime frame
To determine the impact on the proportion of children under five with fever being treated promptly with appropriate anti-malarial treatment, and adhering to the correct dose. Timepoints for both primary and secondary outcomes: At baseline, through household and provider surveys conducted over a four month period prior to the intervention. At follow-up, through household and provider surveys conducted over a three month period, nine to twelve months after the start of the intervention.

Secondary

MeasureTime frame
1. To determine if private sector retailers can deliver AL to appropriate standards of quality for the treatment of fever in children under five years (provision) 2. To determine distribution of benefits of retail sector delivery of AL by socio-economic status (equitable coverage) 3. To explore reasons for the impact observed and identify any challenges in the implementation process Timepoints for both primary and secondary outcomes: At baseline, through household and provider surveys conducted over a four month period prior to the intervention. At follow-up, through household and provider surveys conducted over a three month period, nine to twelve months after the start of the intervention.

Countries

Kenya

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 29, 2026